SCHEMBL3342965

SCHEMBL3342965

CC(S)(Cc1ccccc1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.53
HIF1A Q16665 1/20 0.53
SLC6A2 P23975 1/20 0.48
TAAR1 Q96RJ0 1/20 0.48
PPARG P37231 1/20 0.46
PPARA Q07869 1/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.45
CYP2D6 P10635 1/20 0.45
TRPA1 O75762 1/20 0.44
MMP8 P22894 4/20 0.44
CYP1A2 P05177 3/20 0.44
RECQL P46063 1/20 0.44
BLM P54132 1/20 0.43
MAPK1 P28482 1/20 0.42
FDPS P14324 1/20 0.42
CES2 O00748 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7716562 0.84 BLM (0.44) SMN1; SMN2HIF1APPARACYP3A4ALDH1A1
SCHEMBL3705342 0.80 HIF1A (0.50) SMN1; SMN2HIF1ASLC6A2TAAR1PPARG
SCHEMBL9079706 0.80 LDHA (0.54) SMN1; SMN2PPARGPPARA
SCHEMBL517462 0.78 SMN1; SMN2 (0.57) SMN1; SMN2HIF1ASLC6A2TAAR1PPARG
SCHEMBL27908890 0.78 SMN1; SMN2 (0.57) SMN1; SMN2HIF1ASLC6A2TAAR1PPARG
SCHEMBL10419786 0.78 SMN1; SMN2 (0.57) SMN1; SMN2HIF1ASLC6A2TAAR1PPARG
SCHEMBL8710382 0.78 SMN1; SMN2 (0.57) SMN1; SMN2HIF1ASLC6A2TAAR1PPARG
SCHEMBL28952912 0.78 SMN1; SMN2 (0.57) SMN1; SMN2HIF1ASLC6A2TAAR1PPARG
SCHEMBL13361181 0.78 MMP8 (0.61) SMN1; SMN2HIF1ATAAR1PPARGPPARA
SCHEMBL7290666 0.77 HIF1A (0.47) SMN1; SMN2HIF1ASLC6A2TAAR1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111856881-B Photosensitive resin composition, dry film resist and corresponding element 杭州福斯特电子材料有限公司 2024-03-26 CN disclosed
CN-117311093-A Dry film resist laminate and dry film resist composition 杭州福斯特电子材料有限公司 2023-12-29 CN disclosed
CN-111796483-B Resin composition, mixture, dry film resist and corresponding element 福斯特(安吉)新材料有限公司 2021-06-25 CN disclosed
CN-111796483-A Resin composition, mixture, dry film resist and corresponding element 福斯特(安吉)新材料有限公司 2020-10-20 CN disclosed
CN-102566269-A Color component, color filter and display element JSR K K 2012-07-11 CN disclosed
US-20100160574-A1 Polymerisation Using Chain Transfer Agents THE UNIVERSITY OF LEEDS (GB) 2010-06-24 US disclosed
US-20090215965-A1 POLYMERISATION USING CHAIN TRANSFER AGENTS THE UNIVERSITY OF LEEDS (GB) 2009-08-27 US disclosed
US-20070299221-A1 Polymerisation Using Chain Transfer Agents UNIVERSITY OF LEEDS, THE (GB) 2007-12-27 US disclosed
EP-1697424-A1 POLYMERISATION USING CHAIN TRANSFER AGENTS THE UNIVERSITY OF LEEDS (GB) 2006-09-06 EP disclosed
WO-2005061555-A1 POLYMERISATION USING CHAIN TRANSFER AGENTS THE UNIVERSITY OF LEEDS (GB) 2005-07-07 WO disclosed
EP-1263856-A1 STABILIZER COMPOSITION BASF AKTIENGESELLSCHAFT (DE) 2002-12-11 EP disclosed
WO-2001057122-A1 STABILIZER COMPOSITION BASF AKTIENGESELLSCHAFT (DE) 2001-08-09 WO disclosed
US-5929249-A ANGIOTENSIN II RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1999-07-27 US disclosed
US-5728842-A ANGIOTENSIN II RECEPTOR ANTAGONIST SMITHKLINE BEECHAM CORPORATION (US) 1998-03-17 US disclosed
EP-0653937-A4 CHEMICAL COMPOUNDS. SMITHKLINE BEECHAM CORP (US) 1996-07-31 EP disclosed
EP-0653937-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1995-05-24 EP disclosed
WO-1994000120-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1994-01-06 WO disclosed
US-4460601-A Dipeptides having a methionine residue and possessing a protective action for the liver MAGGIONI FARMACEUTICI, S.P.A. (IT) 1984-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160574-A1 Polymerisation Using Chain Transfer Agents TRRAP, TRMT1, IPO11 SMN1; SMN2 4353/4885HIF1A 1345/4885SLC6A2 2237/4885
US-20090215965-A1 POLYMERISATION USING CHAIN TRANSFER AGENTS TRRAP, TRMT1, IPO11 SMN1; SMN2 4353/4885HIF1A 1345/4885SLC6A2 2237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.